Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2000
03/30/2000CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000CA2344100A1 31 human secreted proteins
03/30/2000CA2344056A1 Use of glp-1 or analogs in treatment of stroke
03/30/2000CA2343645A1 Process for obtaining hmg-coa reductase inhibitors of high purity
03/30/2000CA2343360A1 Human cytoskeleton associated proteins
03/30/2000CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000CA2342742A1 Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications
03/30/2000CA2341170A1 Benzoxazine and benzothiazine derivatives and their use in medicines
03/30/2000CA2340990A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/29/2000EP0988797A1 Compositions for postgastrectomic mineral supply
03/29/2000EP0988379A1 Ldl-receptor
03/29/2000EP0988316A1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
03/29/2000EP0988303A1 PYRROLO 2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
03/29/2000EP0988301A1 Imidazolyl-cyclic acetals
03/29/2000EP0988295A1 Heterocyclic substituted piperidines and uses thereof
03/29/2000EP0988274A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
03/29/2000EP0988108A1 Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strenght, and superabsorbent properties
03/29/2000EP0987957A1 Method for administering viable microorganism composition for poultry
03/29/2000EP0726763B1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
03/29/2000CN1248968A Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCRI receptor
03/29/2000CN1248912A Oral preparation for prophylactic and therapeutic treatment of helicobacter sp. infection
03/29/2000CN1248583A Caryophyllin acid sodium and application in pharmacy thereof
03/29/2000CN1248470A Chinese patent drug-Yibao for treating diabetes
03/29/2000CN1248459A Medicine for weight-reducing and beautifying
03/29/2000CN1050844C Protein kinase C inhibitors
03/29/2000CN1050841C Indole derivatives and medicinal composition having same
03/29/2000CN1050830C Hydroxy-substituted azetidinone compounds and its use in medicine
03/28/2000US6043389 Hydroxy and ether-containing oxyalkylene esters and uses thereof
03/28/2000US6043366 Useful in treating disorders involving the orphanin fq(a seventeen amino acid long peptide) receptor.
03/28/2000US6043284 Anti-atherosclerotic diaryl compounds
03/28/2000US6043281 Aldose reductase inhibitors; treatment or prevention of complications of diabetes
03/28/2000US6043091 Compound of 8 to 30 nucleobases targeted to coding region, 3' or 5'-untranslated region, or start codon of nucleic acid encoding a carbohydrate metabolism enzyme; for antidiabetic agents against non-insulin dependent diabetes
03/28/2000US6043064 Efficient process using nocardia, amycolata, streptomyces, saccharopolyspora, amycolatopsis, saccharothrix, gilbertella or enzyme derived from these microorganisms to produce inhibitor of 3-hydroxy-3-methylglutaryl coenzyme a reductase
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/28/2000US6042823 Ingesting an enzyme selected from amylase and invertase capable of acting in the living body together with a food material containing a substrate for forming oligosaccharide to prevent weight gain, diabetes, gastrointestinal disorders
03/28/2000CA2177968C Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
03/23/2000WO2000015845A1 T-type calcium channel
03/23/2000WO2000015826A2 Leptin induced genes
03/23/2000WO2000015793A2 Human gpcr proteins
03/23/2000WO2000015790A2 Leptin induced genes
03/23/2000WO2000015787A1 Genes encoding for the human and murine death inducer-obliterator-1
03/23/2000WO2000015785A2 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
03/23/2000WO2000015770A2 Human serine/threonine protein kinases
03/23/2000WO2000015659A2 Stomach polypeptide zsig28
03/23/2000WO2000015609A1 Azetidine derivatives, preparation and medicines containing them
03/23/2000WO2000015237A1 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
03/23/2000WO2000015235A1 Method of using tetracycline compounds to enhance interleukin-10 production
03/23/2000WO2000015230A1 METHOD FOR TREATING ATHEROSCLEROSIS EMPLOYING AN aP2 INHIBITOR AND COMBINATION
03/23/2000WO2000015229A1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND COMBINATION
03/23/2000WO2000015224A1 Protein formulations
03/23/2000WO2000015216A1 Therapeutic compositions (ii)
03/23/2000WO2000015215A1 Composition containing cinnamic acid derivatives for preventing or treating elevated blood lipid level-related diseases
03/23/2000WO2000015198A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000WO2000015174A2 Bioflavonoid as blood glucose level lowering agent
03/23/2000WO2000015047A1 Composition containing neohesperidin dihydrochalcone for preventing or treating elevated blood lipid and glucose level-related diseases
03/23/2000WO2000015044A1 Composition containing natural phenolic compounds for preventing or treating elevated blood lipid level-related diseases
03/23/2000WO2000008013A3 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
03/23/2000WO1999046316A3 Enzyme inhibitors
03/23/2000DE19844291A1 New aminoalkylaminoalkyl-substituted benzoxazines or benzothiazines, are nitrogen monoxide synthase inhibitors useful for treating neurodegenerative, inflammatory, autoimmune or cardiovascular disease
03/23/2000DE19843489A1 New benzoylguanidine derivatives are Na+/H+ exchange inhibitors, useful for treatment of ischemia and other circulation disorders, tumors, prostatic hypertrophy and diabetic complications
03/23/2000CA2344401A1 Composition containing natural phenolic compounds for preventing or treating elevated blood lipid level-related diseases
03/23/2000CA2344322A1 Composition containing neohesperidin dihydrochalcone for preventing or treating elevated blood lipid and glucose level-related diseases
03/23/2000CA2344309A1 Method for treating diabetes employing an ap2 inhibitor and combination
03/23/2000CA2344300A1 Method for treating atherosclerosis employing an ap2 inhibitor and combination
03/23/2000CA2344054A1 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
03/23/2000CA2343760A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000CA2343578A1 Human serine/threonine protein kinases
03/23/2000CA2343268A1 Protein formulations
03/23/2000CA2343001A1 Stomach polypeptide zsig28
03/23/2000CA2342965A1 Leptin induced genes
03/23/2000CA2342833A1 Human gpcr proteins
03/23/2000CA2342608A1 Bioflavonoid as blood glucose level lowering agent
03/23/2000CA2341155A1 Genes encoding for the human and murine death inducer-obliterator-1
03/23/2000CA2340586A1 T-type calcium channel
03/23/2000CA2339941A1 Use of cyclic esters of r-3-hydroxybutyrate for treatment of metabolic and neural degenerative disorders
03/22/2000EP0987256A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/22/2000EP0987254A1 Novel cyclic diamine compounds and medicine containing the same
03/22/2000EP0987251A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors
03/22/2000EP0986963A2 Stable, powdery lycopene formulations containing lycopene with a degree of crystallisation of more than 20%
03/22/2000EP0986559A1 1,6-naphthyridine anti-convulsants
03/22/2000EP0986553A1 Dihydropyrimidone derivatives as npy antagonists
03/22/2000EP0986537A2 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
03/22/2000EP0986397A1 Use of leptin antagonists for the treatment of diabet
03/22/2000EP0986395A1 Peptide parathyroid hormone analogs
03/22/2000EP0986389A1 Novel process
03/22/2000EP0986377A1 Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants
03/22/2000CN1248288A Nuclear trasfer with differentiated fetal and adult donor cells
03/22/2000CN1248262A 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
03/22/2000CN1248170A Preparation for treatment of metabolic syndrome containing human growth hormone in combination with cortisol synthesis inhibitor
03/22/2000CN1247758A Medicine specially for treating diabetes
03/22/2000CN1050605C Cycloalkano-indole and -azaindole derivatives, its prepn. and medical composition containing them
03/21/2000US6040329 Substituted indazole analogs
03/21/2000US6040326 3-deoxyglucosone production inhibitor
03/21/2000US6040324 Prophylactic or therapeutic drug for renal diseases
03/21/2000US6040310 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
03/21/2000US6040302 1,4-disubstituted piperazines
03/21/2000US6040292 Methods for treating diabetes
03/21/2000US6040289 Active drug treating obesity
03/21/2000US6040133 D-enzyme compositions and methods of their use
03/21/2000US6039945 Administering purified prothrombinase factor to humans
1 ... 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 ... 1298